Recent IPHA News
- INNATE PHARMA ANNONCE SA PARTICIPATION A UNE PROCHAINE CONFERENCE INVESTISSEURS • Business Wire • 08/01/2024 05:00:00 AM
- Innate Pharma Announces Its Participation in Upcoming Investor Conference • Business Wire • 08/01/2024 05:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024 • Business Wire • 07/25/2024 05:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 10 juillet 2024 • Business Wire • 07/25/2024 05:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 10 juin 2024 • Business Wire • 06/18/2024 05:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024 • Business Wire • 06/18/2024 05:00:00 AM
- Innate Pharma partage de nouveaux résultats concernant l’essai de Phase 1/2 mené par Sanofi évaluant le NK cell engager SAR443579/IPH6101 dans divers cancers du sang • Business Wire • 06/17/2024 05:00:00 AM
- Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial • Business Wire • 06/17/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 10:03:42 AM
- Innate Pharma présente les résultats positifs de l’étude de Phase 2 TELLOMAK évaluant lacutamab dans le mycosis fongoïde • Business Wire • 06/04/2024 05:00:00 AM
- Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides • Business Wire • 06/04/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/28/2024 10:03:49 AM
- Innate Pharma Announces Its Participation in Upcoming Investor Conferences • Business Wire • 05/28/2024 05:00:00 AM
- Innate Pharma annonce sa participation à de prochaines conférences investisseurs • Business Wire • 05/28/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/24/2024 10:35:36 AM
- Innate Pharma partage les abstracts sélectionnés pour le congres annuel de l’ASCO 2024 • Business Wire • 05/24/2024 05:00:00 AM
- Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting • Business Wire • 05/24/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/23/2024 08:00:44 PM
- Outcome of Innate Pharma’s 2024 Annual General Meeting • Business Wire • 05/23/2024 08:00:00 PM
- Résultats de l’Assemblée Générale mixte du 23 mai 2024 • Business Wire • 05/23/2024 08:00:00 PM
- Innate Pharma: Clarification Regarding SAR443579 Designation • Business Wire • 05/21/2024 05:00:00 AM
- Innate Pharma: Clarification concernant le statut de SAR443579 • Business Wire • 05/21/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/15/2024 10:01:12 AM
- Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress • Business Wire • 05/15/2024 05:00:00 AM
- Innate Pharma partage les abstracts sélectionnés pour le congrès 2024 de l’EHA • Business Wire • 05/15/2024 05:00:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM